New Therapies for Lowering Triglyceride-Rich Lipoproteins
- 1 November 2021
- Vol. 78 (18) , 1817-1830
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid DropletsJournal of Biological Chemistry, 2013
- Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without InflammationCirculation, 2013
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart DiseaseJACC, 2013
- Docosahexaenoic and Eicosapentaenoic Acids Segregate Differently between Raft and Nonraft DomainsBiophysical Journal, 2012
- Fish oil — How does it reduce plasma triglycerides?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout LifeAdvances in Nutrition, 2012
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein PhenotypeCirculation, 2010
- Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammationJournal of Lipid Research, 2009
- Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase–Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 ActivationCirculation, 2004
- ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein LipaseJournal of Biological Chemistry, 2002